Taylor & Francis: Open Access Agreement

Answer

Details and eligibility 

  • Review and original research articles can be published immediately Open Access at no cost to the author 

  • Agreement applies to most subscription-based ‘Open Select’ Taylor & Francis journals, fully OA journals, F1000 and Routledge Open journals. 35 subscription-based journals are excluded from the agreement – see list below for details 

  • Agreement applies to funded and unfunded papers 

  • Corresponding author must be affiliated with The University of Manchester 

  • Agreement covers full cost of Article Processing Charge (APC) 

  • This publisher has a wide-ranging portfolio of journals covering most disciplines supported at The University of Manchester, from the Humanities to the Sciences 

How to access the agreement  

During the submission process, corresponding authors must use their university email address in order to be identified as eligible for the deal. 

Our Open Access agreements 

Find information about our other active Open Access agreements

Further support

Need any help? You can find more articles about other Open Access-related topics or get in touch with the team.

Excluded subscription-based journals

Subscription-based journals excluded from agreement: 

  • Critical Reviews in Biochemistry and Molecular Biology 
  • Current Medical Research and Opinion 
  • Expert Opinion on Biological Therapy 
  • Expert Opinion on Drug Discovery 
  • Expert Opinion on Drug Delivery 
  • Expert Opinion on Drug Safety 
  • Expert Opinion on Investigational Drugs 
  • Expert Opinion on Emerging Drugs 
  • Expert Opinion on Drug Metabolism & Toxicology 
  • Expert Opinion on Orphan Drugs 
  • Expert Opinion on Pharmacotherapy 
  • Expert Review of Medical Devices 
  • Expert Review of Endocrinology & Metabolism 
  • Expert Review of Gastroenterology & Hepatology 
  • Expert Review of Clinical Pharmacology 
  • Expert Review of Cardiovascular Therapy 
  • Expert Review of Ophthalmology 
  • Expert Review of Clinical Immunology 
  • Expert Review of Neurotherapeutics 
  • Expert Review of Molecular Diagnostics 
  • Expert Review of Pharmacoeconomics & Outcomes Research 
  • Expert Review of Hematology 
  • Expert Review of Proteomics 
  • Expert Review of Vaccines 
  • Expert Review of Respiratory Medicine 
  • Expert Review of Anticancer Therapy 
  • Expert Review of Anti-infective Therapy 
  • Expert Opinion on Therapeutic Patents 
  • Expert Opinion on Therapeutic Targets 
  • Hospital Practice 
  • Critical Reviews in Microbiology 
  • Postgraduate Medicine 
  • Platelets 
  • Polymer Reviews 
  • Expert Review of Precision Medicine and Drug Development 
  • Last Updated 24 Jan 2025
  • Views 120
  • Answered By Steve Carlton

FAQ Actions

Was this helpful? 0 0